Infectious Diseases (all articles)
COVID-19 antibodies persist at least nine months after infection – “98.8 percent of people infected in February/March showed detectable levels of antibodies in November”.
22 Jul, 2021 | 11:14h | UTCNews release: COVID-19 antibodies persist at least nine months after infection – Imperial College London
Original study: SARS-CoV-2 antibody dynamics and transmission from community-wide serological testing in the Italian municipality of Vo’ – Nature Communications
RCT: Dapagliflozin in patients with cardiometabolic risk factors hospitalized with COVID-19 – safe, but no statistically significant risk reduction in organ dysfunction or death.
22 Jul, 2021 | 11:08h | UTCCommentary: Dapagliflozin in patients with COVID-19: truth or dare – The Lancet Diabetes & Endocrinology
Should children get COVID vaccines? What the science says.
22 Jul, 2021 | 11:06h | UTCShould children get COVID vaccines? What the science says – Nature
Opinion | The benefits of a COVID vaccine far outweigh the small risk of treatable heart inflammation.
22 Jul, 2021 | 10:57h | UTC
Analysis finds benefits of COVID-19 vaccination outweigh risks of rare cases of myocarditis.
22 Jul, 2021 | 11:05h | UTCNews release: Study finds benefits of COVID-19 vaccination outweigh risks of rare cases of myocarditis – American Heart Association
Original study: Myocarditis with COVID-19 mRNA Vaccines – Circulation
Commentary: Myocarditis and COVID-19 Vaccines: New Review Tackles Knowns, Unknowns – TCTMD
Commentary on Twitter
Just published ahead of print- Myocarditis with Covid mRNA Vaccines https://t.co/mc2yrr5pDV Mechanisms, benefit of COVID-19 mRNA vaccination over low risk, management strategies – review of all myocarditis cases published to date, CDC&other reports @PeterHotez @ishannovation
— BiykemBozkurt (@BiykemB) July 20, 2021
WHO Guidelines for the management of symptomatic sexually transmitted infections.
22 Jul, 2021 | 10:54h | UTCNews release: Launch WHO guidelines for the management of symptomatic sexually transmitted infection – World Health Organization
Commentary on Twitter
Great see @WHO new guidelines #STIs https://t.co/SgkCtcMDbv BUT hope last edition w syndromic management. Must deliver diagnostic capacity LMICs pic.twitter.com/B7ugeUpIRG
— Michael Marks (@dr_michaelmarks) July 17, 2021
Opinion | Kids aren’t just littler adults – here’s why they need their own clinical trials for a COVID-19 vaccine.
22 Jul, 2021 | 10:55h | UTC
A Narrative Review on the Role of Staphylococcus aureus Bacteriuria in S. aureus Bacteremia.
22 Jul, 2021 | 10:37h | UTC
Commentary on Twitter
✨If you have Staph in urine check blood culture✨
💥Excellent narrative review on the role of Staphylococcus aureus Bacteriuria in S. aureus Bacteremia
Epidemiology and pathogenesis of SABU in patients with SAB💥 #IDTwitter #ofid https://t.co/wioI3I528z pic.twitter.com/54jVQEBeDW— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) March 30, 2021
Exploring the gap between excess mortality and COVID-19 deaths in 67 countries.
21 Jul, 2021 | 10:51h | UTCExploring the Gap Between Excess Mortality and COVID-19 Deaths in 67 Countries – JAMA Network Open
More than 1.5 million children lost a primary or secondary caregiver due to the COVID-19 pandemic.
21 Jul, 2021 | 10:52h | UTCNews release: More than 1.5 million children lost a primary or secondary caregiver due to the COVID-19 pandemic – NIH News Releases
Original study: Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study – The Lancet
Invited commentary: Answering the call to support youth orphaned by COVID-19 – The Lancet
Related: Covid-19 Has Created Thousands Of Newly Single Parents And Orphans
Commentary on Twitter (thread – click for more)
NEW—Over 1.5 million children lost a parent, custodial grandparent, or other relative who cared for them during the first 14 months of the #COVID19 #pandemic, first global study estimates.
🔗 Read https://t.co/Ug2ADTvO8G (1/2)
— The Lancet (@TheLancet) July 20, 2021
Report: Three new estimates of India’s all-cause excess mortality during the COVID-19 Pandemic – pandemic death toll estimated to be between 3.4 million and 4.9 million excess deaths.
21 Jul, 2021 | 10:49h | UTCCommentaries: India’s pandemic death toll could be in the millions – Associated Press AND Covid-19: India excess deaths cross four million, says study – BBC AND India’s true pandemic death toll is likely to be well over 3 million, a new study finds. – The New York Times AND India’s excess deaths during Covid ‘could be 10 times official toll’ – The Guardian
Commentary on Twitter
India's official COVID death toll is 400,000.
But new research shows the death toll could be much higher, up to 4 million.
↘️ @abhishekecon @JustinSandefur & @arvindsubraman breakdown the numbers from three data estimates: https://t.co/rdOcZvHZQU.
— Center for Global Development (@CGDev) July 20, 2021
Perspective | Potential COVID-19 endgame scenarios: eradication, elimination, cohabitation, or conflagration?
21 Jul, 2021 | 10:48h | UTC
Is the cure really worse than the disease? The health impacts of lockdowns during COVID-19 – “While there are certainly costs to be expected from intervening against COVID-19—every decision has a cost, after all—the counterfactual of an unmitigated epidemic makes these restrictions far less damaging than some have suggested”.
21 Jul, 2021 | 10:46h | UTCCommentaries: Expert reaction to a narrative review looking at the health impacts of lockdowns – Science Media Centre AND Lockdowns do not harm health more than Covid, say researchers – The Guardian
Commentary on Twitter (thread – click for more)
https://twitter.com/GYamey/status/1417509867498229760
Cohort study: Sickle cell disorders and severe COVID-19 outcomes – “Our analysis estimated a 4-fold increased risk for COVID-19–related hospitalization and a 2.6-fold increased risk for COVID-19–related death for sickle cell disease”.
21 Jul, 2021 | 10:44h | UTCSickle Cell Disorders and Severe COVID-19 Outcomes: A Cohort Study – Annals of Internal Medicine
WHO Guidance for clinical case management of thrombosis with thrombocytopenia syndrome (TTS) following vaccination to prevent coronavirus disease (COVID-19).
20 Jul, 2021 | 10:29h | UTCRelated Guidance: AHA/ASA Guidance: Diagnosis and Management of Cerebral Venous Sinus Thrombosis with Vaccine-Induced Thrombotic Thrombocytopenia – “No heparin products in any dose should be given.” AND ISTH Interim Guidance for the Diagnosis and Treatment on Vaccine Induced Immune Thrombotic Thrombocytopenia
WHO and UNICEF warn of a decline in vaccinations during COVID-19.
20 Jul, 2021 | 10:27h | UTCWHO and UNICEF warn of a decline in vaccinations during COVID-19 – World Health Organization
Related: Millions of children worldwide missed routine vaccinations during the pandemic, study suggests.
International Registry: Ischemic and hemorrhagic stroke among critically ill patients with Covid-19.
20 Jul, 2021 | 10:21h | UTCRelated: SARS-CoV-2 and Stroke Characteristics – higher rate of large vessel occlusions and stroke in young patients AND Case series of 18 male adults aged 50 years or younger with acute ischemic stroke during the convalescent phase of asymptomatic Covid-19 AND Case-control study: COVID-19-associated stroke is associated with worse outcomes and increased mortality AND Pictorial essay: Neurological emergencies associated with COVID-19: stroke and beyond AND Characteristics and Outcomes in Patients With COVID-19 and Acute Ischemic Stroke AND Risk of Ischemic Stroke in Patients with COVID-19 vs. Patients with Influenza
WHO warns that HIV infection increases risk of severe and critical COVID-19.
20 Jul, 2021 | 10:24h | UTCNews release: WHO warns that HIV infection increases risk of severe and critical COVID-19 – World Health Organization
Commentary on Twitter (thread – click for more)
🆕 report confirms that #HIV infection is a significant independent risk factor for both severe/critical #COVID19 presentation at hospital admission & in-hospital mortality. 23.1% of all people living with HIV who were hospitalized with COVID-19, died.
👉 https://t.co/UBd0OyFKnd pic.twitter.com/UHLo9RPa1g
— World Health Organization (WHO) (@WHO) July 16, 2021
Experts recommend Covid jabs for some under-18s in UK – “advice is that 16 to 18-year-olds can be offered a Pfizer jab if they are in a priority group or live with someone who has a weakened immune system”.
20 Jul, 2021 | 10:15h | UTCCommentaries: Experts recommend Covid jabs for some under-18s in UK – BBC
What vaccinated people should know about Covid-19 exposure, tests and more.
20 Jul, 2021 | 10:17h | UTCWhat vaccinated people should know about Covid-19 exposure, tests and more – CNN
Editorial: Defining covid-19 elimination.
20 Jul, 2021 | 10:20h | UTCDefining covid-19 elimination – The BMJ
RCT: more data showing Azithromycin is not better than placebo in patients with Covid-19.
18 Jul, 2021 | 23:54h | UTCRelated: RCT: Another study shows Azithromycin does not improve outcomes in patients with Covid-19. (several articles on the subject)
Commentary on Twitter
Among outpatients with #SARSCoV2 infection, treatment with a single dose of oral #azithromycin compared with placebo did not result in a greater likelihood of being free of symptoms at day 14 https://t.co/dYDcSyGtwd #COVID19
— JAMA (@JAMA_current) July 16, 2021
Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020.
20 Jul, 2021 | 10:04h | UTCRelated: Millions of children worldwide missed routine vaccinations during the pandemic, study suggests.
Review: Symptoms, complications and management of long COVID.
18 Jul, 2021 | 23:46h | UTCCommentary: Long COVID: More likely in patients with 5+ symptoms in first week of infection – SAGE Publications
Commentary on Twitter
Pooled prevalence data in this review showed the 10 most prevalent reported symptoms of long covid were: fatigue, shortness of breath, muscle pain, joint pain, headache, cough, chest pain, altered smell, altered taste and diarrhoea.
https://t.co/ww5HM1s7vm— KK Cheng (@KKCheng4) July 16, 2021
Position Paper: Recommendations for the use of topical inhalant budesonide in COVID-19.
18 Jul, 2021 | 23:53h | UTCRecommendations for use of topical inhalant budesonide in COVID-19 – HNO
Related: RCT: Inhaled budesonide shortens recovery time in non-hospitalized patients with COVID-19 AND Phase 2 RCT: Inhaled budesonide shows promise for the treatment of early COVID-19